Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03126968 · ClinicalTrials.gov registry record · Phase 2
Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT03126968 is a Phase 2 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 66 participants.
The verdict
NCT03126968, a Phase 2 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
Bleeding poses potential for significant complication after transbronchial lung biopsies. The investigators hypothesize that prophylactic intrabronchial instillation of topical epinephrine will reduce the likelihood of bleeding. The investigators plan a double-blind, placebo controlled trial to evaluate this hypothesis.
Interventions
- DRUG Placebos
- DRUG Topical epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2021-07-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03126968
The ClinicalTrials.gov registry entry for NCT03126968 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebos is the first listed.
NCT03126968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03126968 about?
NCT03126968 is a clinical study titled "Prophylactic Topical Epinephrine to Reduce Bleeding in Transbronchial Lung Biopsies". Bleeding poses potential for significant complication after transbronchial lung biopsies. The investigators hypothesize that prophylactic intrabronchial instillation of topical epinephrine will reduce the likelihood of bleeding. The investigators plan a double-blind, placebo controlled trial to eval...
What is the current status of trial NCT03126968?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2017-07-01. Estimated completion is 2021-07-02.
What interventions are being tested in trial NCT03126968?
The interventions under investigation include: Placebos (DRUG), Topical epinephrine (DRUG).
Who is sponsoring clinical trial NCT03126968?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.